I am having a hard time understanding why this is not great news for current and future Vystar shareholders. If you are a current Vystar shareholder and have 1M shares you can sell today at $20,000. If you hold until January 5, you get and additional $60,000 of Rx Air stock making the effective price of Vystar today at 8 cents. Think selling will dry up. On the other hand the only way to acquire RxAir shares is to buy Vystar shares over the next few months. Buying will go up and a supply demand imbalance will occur. <br /> Vystar is also giving 80% of the RxAir shares to Vystar shareholders while retaining 20%. This allows for the dividend to be tax free and any taxes on subsequent sales are pushed to 2023 which is neat. <br /> The $2.00 per share opening price is a given as that is the price of the last Private tranche according to the press release and the share base is only 35-36M and not 1.2B <br /> Should be an interesting few months to see if the supply demand imbalance develops.